Beth LaVasseur

2.2k total citations · 1 hit paper
16 papers, 1.6k citations indexed

About

Beth LaVasseur is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Genetics. According to data from OpenAlex, Beth LaVasseur has authored 16 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Genetics. Recurrent topics in Beth LaVasseur's work include Menopause: Health Impacts and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). Beth LaVasseur is often cited by papers focused on Menopause: Health Impacts and Treatments (4 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). Beth LaVasseur collaborates with scholars based in United States. Beth LaVasseur's co-authors include Charles L. Loprinzi, Debra L. Barton, Paul J. Novotny, Jeff A. Sloan, Harold E. Windschitl, Shaker R. Dakhil, John W. Kugler, Bradley J. Christensen, Teresa A. Rummans and James A. Mailliard and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Journal of Pain.

In The Last Decade

Beth LaVasseur

16 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

2000 539 citations Charles L. Loprinzi, John W. Kugler et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Beth LaVasseur United States	10	960	749	517	513	216	16	1.6k
Susan K. Quella United States	16	1.2k 1.3×	1.0k 1.3×	565 1.1×	692 1.3×	362 1.7×	22	2.2k
Bradley J. Christensen United States	10	568 0.6×	459 0.6×	248 0.5×	495 1.0×	171 0.8×	16	1.5k
Malini Iyengar United States	18	463 0.5×	336 0.4×	180 0.3×	177 0.3×	95 0.4×	26	1.6k
Erin J. Aiello United States	19	235 0.2×	268 0.4×	179 0.3×	801 1.6×	344 1.6×	25	1.9k
Alan Herd United States	7	1.1k 1.1×	863 1.2×	289 0.6×	228 0.4×	71 0.3×	7	1.8k
Kelly Ehrlich United States	20	397 0.4×	243 0.3×	289 0.6×	80 0.2×	50 0.2×	43	1.0k
Veronica A. Ravnikar United States	18	1.2k 1.3×	929 1.2×	415 0.8×	276 0.5×	96 0.4×	31	2.3k
Margery Gass United States	8	381 0.4×	359 0.5×	305 0.6×	232 0.5×	37 0.2×	13	1.1k
F Grodstein United States	17	240 0.3×	219 0.3×	222 0.4×	174 0.3×	137 0.6×	32	1.4k
Jessica L. Broadbent Australia	11	388 0.4×	330 0.4×	323 0.6×	59 0.1×	51 0.2×	12	840

Countries citing papers authored by Beth LaVasseur

Since Specialization

Citations

This map shows the geographic impact of Beth LaVasseur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beth LaVasseur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beth LaVasseur more than expected).

Fields of papers citing papers by Beth LaVasseur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beth LaVasseur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beth LaVasseur. The network helps show where Beth LaVasseur may publish in the future.

Co-authorship network of co-authors of Beth LaVasseur

This figure shows the co-authorship network connecting the top 25 collaborators of Beth LaVasseur. A scholar is included among the top collaborators of Beth LaVasseur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beth LaVasseur. Beth LaVasseur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Malani, Anurag N., et al.. (2021). Administration of Monoclonal Antibody for COVID-19 in Patient Homes. JAMA Network Open. 4(10). e2129388–e2129388. 6 indexed citations

Knoerl, Robert, Debra L. Barton, Janean E. Holden, et al.. (2018). Potential mediators of improvement in painful chemotherapy-induced peripheral neuropathy via a web-based cognitive behavioural intervention. Canadian Oncology Nursing Journal. 28(3). 178–183. 2 indexed citations

Knoerl, Robert, Elizabeth Smith, Debra L. Barton, et al.. (2017). Self-Guided Online Cognitive Behavioral Strategies for Chemotherapy-Induced Peripheral Neuropathy: A Multicenter, Pilot, Randomized, Wait-List Controlled Trial. Journal of Pain. 19(4). 382–394. 40 indexed citations

McCabe, Vita V., et al.. (2017). Implementation and outcomes of lung cancer screening in a community health care system.. Journal of Clinical Oncology. 35(15_suppl). e13035–e13035. 1 indexed citations

Harrison, Jordan M., et al.. (2016). Factors associated with toxicity-related service use among community oncology patients.. Journal of Clinical Oncology. 34(7_suppl). 133–133. 2 indexed citations

Harrison, Jordan M., et al.. (2016). Toxicity-Related Factors Associated With Use of Services Among Community Oncology Patients. Journal of Oncology Practice. 12(8). e818–e827. 19 indexed citations

Dimond, Eileen, Robin Zoň, Diane St. Germain, et al.. (2014). The clinical trial assessment of infrastructure matrix tool (CT AIM) to improve the quality of research conduct in the community.. Journal of Clinical Oncology. 32(15_suppl). 6512–6512. 2 indexed citations

Barton, Debra L., Philip J. Atherton, Brent A. Bauer, et al.. (2011). The Use of Valeriana officinalis (Valerian) in Improving Sleep in Patients Who Are Undergoing Treatment for Cancer: A Phase III Randomized, Placebo-Controlled, Double-Blind Study (NCCTG Trial, N01C5). PubMed. 9(1). 24–31. 53 indexed citations

Barton, Debra L., Beth LaVasseur, Jeff A. Sloan, et al.. (2010). Phase III, Placebo-Controlled Trial of Three Doses of Citalopram for the Treatment of Hot Flashes: NCCTG Trial N05C9. Journal of Clinical Oncology. 28(20). 3278–3283. 94 indexed citations

10.

Blayney, Douglas W., et al.. (2009). Partnering With Payers for Success: Quality Oncology Practice Initiative, Blue Cross Blue Shield of Michigan, and the Michigan Oncology Quality Consortium. Journal of Oncology Practice. 5(6). 281–284. 11 indexed citations

11.

Barton, Debra L., Beth LaVasseur, Jeff A. Sloan, et al.. (2008). A phase III trial evaluating three doses of citalopram for hot flashes: NCCTG trial N05C9. Journal of Clinical Oncology. 26(15_suppl). 9538–9538. 8 indexed citations

12.

Pockaj, Barbara A., James Gallagher, Charles L. Loprinzi, et al.. (2006). Phase III Double-Blind, Randomized, Placebo-Controlled Crossover Trial of Black Cohosh in the Management of Hot Flashes: NCCTG Trial N01CC¹. Journal of Clinical Oncology. 24(18). 2836–2841. 130 indexed citations

13.

Sloan, Jeff A., Charles L. Loprinzi, Paul J. Novotny, et al.. (2001). Methodologic Lessons Learned From Hot Flash Studies. Journal of Clinical Oncology. 19(23). 4280–4290. 374 indexed citations

14.

Loprinzi, Charles L., John W. Kugler, James A. Mailliard, et al.. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. The Lancet. 356(9247). 2059–2063. 539 indexed citations breakdown →

15.

Quella, Susan K., Charles L. Loprinzi, Debra L. Barton, et al.. (2000). Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group Trial. Journal of Clinical Oncology. 18(5). 1068–1068. 284 indexed citations

16.

Okuno, Scott H., Charles L. Loprinzi, Jeff A. Sloan, et al.. (1999). Phase III Controlled Evaluation of Glutamine for Decreasing Stomatitis in Patients Receiving Fluorouracil (5-FU)-Based Chemotherapy. American Journal of Clinical Oncology. 22(3). 258–261. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact